Green tea extract induces interleukin-8 (IL-8) mRNA and protein expression but specifically inhibits IL-8 secretion in Caco-2 cells

Planta Medica

Volumn 72, Issue 8, 2006, Pages 697-702

  Netsch, M I ^a,b   Gutmann, H ^a   Aydogan, C ^b   Drewe, Jürgen ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Frutarom Switzerland Ltd   (Switzerland)

^c University Clinics   (Switzerland)

Author keywords

Camellia sinensis (L.) O. Kuntze; Chemokines; Green tea; Interleukin 8; Theaceae

Indexed keywords

BREFELDIN A; CELL PROTEIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INCUBATION TIME; INTESTINE CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEA; TRANSPORT VESICLE;

ANTIOXIDANTS; CACO-2 CELLS; CAMELLIA SINENSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; PHYTOTHERAPY; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33746032541     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-931597     Document Type: Article

References (25)

1. Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997; 113: 1214-23
2. Woywodt A, Neustock P, Kruse A, Schwarting K, Ludwig D, Stange EF et al. Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease. Eur Cytokine Netw 1994; 5: 387-95
3. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000; 51: 289-98
4. MacDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immuno-pathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998; 4: 54-67
5. Puleston J, Cooper M, Murch S, Bid K, Makh S, Ashwood P et al. A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther 2005; 21: 109-20
6. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994; 55: 97-179
7. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8
8. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukocyte Biol 1994; 56: 559-64
9. Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MN. Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin-8. Gastroentereology 1993; 105: 1689-97
10. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990; 31: 686-9
11. Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992; 103: 65-71
12. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154: 2434-40
13. Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong AN. Epigallocatechin-3- gallate-induced stress signals in HAT-29 human colon adenocarcinoma cells. Carcinogenesis 2003; 24: 1369-78
14. Varilek GW, Yang F, Lee EY, deVilliers WJ, Zhong J, Oz HS et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001; 131: 2034-9
15. Porath D, Riegger C, Drewe J, Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005; 315: 1172-80
16. Chen PC, Wheeler DS, Malhotra V, Odoms K, Denenberg AG, Wong HR. A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 2002; 26: 233-41
17. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 1992; 116: 1071-80
18. Netsch MI, Gutmann H, Luescher S, Brill S, Schmidlin CB, Kreuter MH et al. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Planta Med 2005; 71: 35-41
19. Netsch MI, Gutmann H, Schmidlin CB, Aydogan C, Drewe J. Induction of CYP1A by green tea extract in human intestinal cell lines. Planta Med, 2006, in press
20. Vallee S, Laforest S, Fouchier F, Montera MP, Penel C, Champion S. Cytokine-induced upregulation of NF-kappaB, IL-8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCdelta. Exp Cell Res 2004; 297: 165-85
21. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 1997; 158: 226-34
22. MacDermott RP. Chemokines in the inflammatory bowel diseases. J Clin Immunol 1999; 19: 266-72
23. Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000; 47: 79-87
24. Komatsu M, Kobayashi D, Saito K, Furuya D, Yagihashi A, Araake H et al. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem 2001; 47: 1297-301
25. Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002; 11: 1025-32